Edition:
United Kingdom

Rhoen Klinikum AG (RHKG.DE)

RHKG.DE on Xetra

25.35EUR
3:13pm BST
Change (% chg)

€-0.20 (-0.78%)
Prev Close
€25.55
Open
€25.20
Day's High
€25.55
Day's Low
€25.20
Volume
8,899
Avg. Vol
29,647
52-wk High
€27.10
52-wk Low
€21.06

Latest Key Developments (Source: Significant Developments)

Rhoen Klinikum Q1 EBITDA Up 4 Pct To EUR 28.7 Mln
Friday, 3 May 2019 

May 3 (Reuters) - Rhoen Klinikum AG ::DGAP-NEWS: RHÖN-KLINIKUM AG CLOSES FIRST QUARTER 2019 WITH PLEASING REVENUES AND EARNINGS AND CONFIRMS ITS GUIDANCE FOR 2019.Q1 EBITDA ROSE 4 PERCENT TO 28.7 MILLION EUR.Q1 REVENUE ROSE 4 PERCENT TO 324.2 MILLION EUR.GUIDANCE FOR 2019 CONFIRMED.CONSOLIDATED PROFIT DROPPED FROM EURO 10.4 MILLION TO EURO 8.9 MILLION (-14.4 %) IN Q1 OF 2019.TO PROPOSE TO PAY A DIVIDEND IN AMOUNT OF EURO 0.29 PER NON-PAR SHARE ENTITLED TO DIVIDEND.  Full Article

Rhoen-Klinikum Acquires Minority Share In Software Provider Tiplu GmbH
Wednesday, 13 Feb 2019 

Feb 13 (Reuters) - Rhoen Klinikum AG ::DGAP-NEWS: RHÖN-KLINIKUM AG ACQUIRES MINORITY SHARE IN SOFTWARE PROVIDER TIPLU GMBH.  Full Article

Rhön-Klinikum Secures Future Of Marburg Ion Beam Therapy Center (MIT)
Friday, 16 Nov 2018 

Nov 16 (Reuters) - Rhoen Klinikum AG ::DGAP-NEWS: RHÖN-KLINIKUM AG SECURES FUTURE OF MARBURG ION BEAM THERAPY CENTER (MIT).BUYS 75.1 PER CENT INTEREST IN MIT GMBH CURRENTLY HELD BY UNIVERSITÄTSKLINIKUM HEIDELBERG (UKHD).TRANSACTION EFFECTIVE FROM 1 JANUARY 2019.TO SECURE BUSINESS OPERATIONS AT MIT GMBH OVER COMING FINANCIAL YEARS.MANAGEMENT OF MIT GMBH TO WITHDRAW INSOLVENCY APPLICATION WITHIN REQUIRED TIME LIMIT.AGREEMENT WILL IN NO WAY AFFECT GUIDANCE OF RHÖN-KLINIKUM AG FOR 2018.FOR CURRENT FINANCIAL YEAR 2018, RHÖN-KLINIKUM AG CONFIRMS EXISTING FORECAST.  Full Article

Rhoen Klinikum FY Net Profit Of 36.7 Million Euros
Friday, 23 Feb 2018 

Feb 23 (Reuters) - RHOEN KLINIKUM AG ::FY NET PROFIT 36.7 MILLION EUR.FY REVENUE 1.21 BILLION EUR.FY CORPORATE REVENUES STOOD AT EURO 1.21 BILLION.FOR CURRENT FINANCIAL YEAR 2018 WE EXPECT REVENUES IN AMOUNT OF EURO 1.24 BILLION PLUS/MINUS 5 PERCENT.‍FY EBITDA STANDS AT EURO 97.8 MILLION​.FOR 2018 EXPECTS A MUCH HIGHER AMOUNT FOR EBITDA OF BETWEEN EURO 117.5 MILLION AND EURO 127.5 MILLION.  Full Article

Rhoen-Klinikum Q3 EBITDA down at 27.4 million euros
Friday, 10 Nov 2017 

Nov 10 (Reuters) - RHOEN KLINIKUM AG ::INTERIM REPORT FOR THE THIRD QUARTER OF 2017: RHÖN-KLINIKUM AG ON THE RIGHT TRACK - ACTION PLAN FOR IMPROVING PROFITABILITY SUCCESSFULLY COMMENCED - FORECAST FOR 2017 CONFIRMED.RHOEN KLINIKUM AG - 2017 OUTLOOK: REVENUES BETWEEN EURO 1.20 BILLION AND EURO 1.23 BILLION; EBITDA BETWEEN EURO 85 MILLION AND EURO 105 MILLION​.Q3 ‍REVENUES ROSE BY 3.2 PERCENT TO EURO 304.0 MILLION (PREVIOUS YEAR: EURO 294.7 MILLION)​.Q3 ‍EBITDA AT EURO 27.4 MILLION (PREVIOUS YEAR: EURO 28.1 MILLION)​.  Full Article

Rhoen Klinikum H1 EBITDA at 50.2 million euros
Thursday, 3 Aug 2017 

Aug 3 (Reuters) - RHOEN KLINIKUM AG ::H1 EBITDA 50.2 MILLION EUR.H1 REVENUE 598.4 MILLION EUR.‍OUTLOOK FOR 2017: REVENUES BETWEEN EURO 1.20 BILLION AND EURO 1.23 BILLION, EBITDA BETWEEN EURO 85 MILLION AND EURO 105 MILLION​.‍H1 EBITDA IS AT EURO 50.2 MILLION​.  Full Article

Rhoen Klinikum: Bernard Grosse Broermann refers to his notification
Wednesday, 14 Jun 2017 

June 14 (Reuters) - RHOEN KLINIKUM AG ::DR. BERNARD GROSSE BROERMANN CONSIDERS HOLDING IN CORPORATION AS A LONG-TERM STRATEGIC INVESTMENT.DR. BERNARD GROSSE BROERMANN IS EVENTUALLY WILLING TO OBTAIN FURTHER VOTING RIGHTS BY ACQUISITION OR ANY OTHER WAY WITHIN NEXT 12 MONTHS - DEPENDING ON SHARE PRICE AND GENERAL PERFORMANCE OF CORPORATION.DR. BERNARD GROSSE BROERMANN INTENDS TO OBTAIN AN APPROPRIATE REPRESENTATION ON SUPERVISORY BOARD AND INTENDS TO EXECUTE HIS VOTING RIGHTS ACCORDINGLY.DR. BERNARD GROSSE BROERMANN DOES NOT INTEND TO ESSENTIALLY CHANGE CAPITAL STRUCTURE OF CORPORATION, ESPECIALLY WITH REGARDS TO RATIO OF INTERNAL/OUTSIDE FINANCING AND DIVIDEND POLICY.  Full Article

Rhoen Klinikum sees FY revenues of EUR 1.20 bln - 1.23 bln
Wednesday, 7 Jun 2017 

June 7 (Reuters) - RHOEN KLINIKUM AG ::‍FOR CURRENT FINANCIAL YEAR 2017 COMPANY EXPECTS REVENUES OF EURO 1.20 BILLION TO EURO 1.23 BILLION AND EBITDA OF EURO 85 MILLION TO EURO 105 MILLION​.‍PROPOSAL TO AUTHORIZE COMPANY TO ACQUIRE UP TO 10 PERCENT OF EXISTING SHARE CAPITAL HAS NOT BEEN ACCEPTED​.  Full Article

German stocks - Factors to watch on May 3

BERLIN, May 3 The following are some of the factors that may move German stocks on Friday: